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The World Health Organization has identified studies of the role of
host genetics on susceptibility to severe influenza as a priority. A
systematic review was conducted in June 2011 to summarise the
evidence on the role of host genetics in susceptibility to influenza,
and this report updates that previously published review. Animal
studies suggest that genetic control of susceptibility to severe
influenza in mice is complex and not controlled by a single locus,
but there is encouraging evidence that some of the host genetic
determinants of susceptibility to severe disease may be common
across influenza subtypes. Although a number of studies on genetic
susceptibility to influenza in humans have been published recently,
all are underpowered and unreplicated, so do not provide robust
statistical evidence of an association between the identified genetic
loci and susceptibility. One study does however present convincing
functional evidence for an important role for IFITM3 in
susceptibility to severe influenza in mice, and some evidence that
this may also be important in human A/H1N1/pdm2009 infection.
Keywords Animal model, host genetics, human influenza, suscep-
tibility, systematic review.
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Introduction
There is great variability in the severity of disease resulting
from infection with influenza viruses, and there are three
main determinants of this variability: the intrinsic patho-
genicity of the virus, acquired host factors (such as immunity
and comorbidity) and intrinsic host susceptibility. Whilst the
viral genetic determinants of influenza severity and host
immunity have been intensively studied, host genetic deter-
minants are much less well studied.1,2 Around one-quarter to
one-half of patients with severe pandemic influenza A
(H1N1)pdm09 were previously healthy, with no identified
coexisting medical condition or other predisposing factors.3
Whilst unrecognised acquired susceptibility factors, such as
co-infection, the composition of the upper respiratory tract
microbiome or nutritional imbalances (such as vitamin D)
may play a role in susceptibility to severe disease in
apparently ‘healthy’ individuals, host genetics may also be
important. The study of host genetic factors involved in
susceptibility to influenza has the potential to provide a
better understanding of the biological pathways leading to
severe influenza, which in turn may reveal new therapeutic
avenues beyond the few currently available.4 In 2009, the
World Health Organization identified studies of the role of
host genetic factors on susceptibility to severe influenza as a
priority.5,6 In March 2012, a systematic review summarising
the evidence that host genetic factors play a role in human
susceptibility to influenza virus infection or disease was
published, and this short report updates that review to
include significant new data.1
Methods
The systematic review was conducted and reported in
accordance with the PRISMA guidelines, and the protocol
was registered on the international prospective register of
systematic reviews (PROSPERO registration number:
CRD42011001380. Available at: www.crd.york.ac.uk/prospero/).
The full methods are published elsewhere, and the complete
search strategy can be found in the protocol available on the
PROSPERO website.1 Briefly, we conducted a systematic
review to summarise relevant published and unpublished
evidence of host genetic factors influencing the risk of
influenza infection or disease (illness following infection).
The search strategy was initially run on 26th June 2011 and
was rerun and updated on 11th September 2012.
Results
An additional 149 unique articles published in English since
26th June 2011 were identified, and the titles and abstracts
were reviewed. Five were considered relevant and were
obtained. A further three relevant articles were identified
through a review of the bibliographies of the five selected
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papers and personal communications. A total of eight new
articles are therefore included in this update. The newly
identified publications include one review paper, two animal
studies, four human studies and one mixed methods study
and are shown in Table 1.
Animal studies
Boivin et al.7 aimed to identify candidate genomic loci
involved in the control of A/HK/1/68-MA20 (H3N2) in 29
recombinant congenic mouse strains using the co-localisa-
tion of clinical quantitative trait loci (cQTL) and RNA
expression quantitative trait loci (eQTL) to identify genomic
areas of interest. The recombinant congenic mouse strains
were bred from susceptible (A/J) and resistant (C57BL/6J)
mice. The most significant loci identified were Hc on
chromosome 2, and Pla2 g7 and Tnfrsf21 on chromosome
17. The authors found the responses to be sex-specific, with
the QTL on chromosome two being associated with suscep-
tibility only in females and the QTL on chromosome 17 only
in males. Whilst Boon et al.8,9 also identified an association
with the Hc gene on chromosome 2 in their 2009 study of
susceptibility to A/H5N1, it was not replicated in their 2011
study. The proteins encoded by the genomic regions
identified on chromosome 17 have not previously been
associated with susceptibility to influenza.
Bottomly et al.10 examined genetic control of host
responses to influenza A/PR/8/34 (H1N1) infection by
mapping eQTL. ‘High’ and ‘low’ response phenotypes
amongst 44 pre-Collaborative Cross mouse strains were
identified based on weight loss and viral replication as
assessed by immunohistochemical straining of lung tissue at
4 days post-infection. Expression quantitative trait loci
mapping was performed on RNA transcripts that were
differentially expressed in high and low responders. Twenty-
one statistically significant eQTL were identified: 10 that
were up regulated in the high responders and 11 up
regulated in the low responders. None of these 21 genes
have previously been identified as important in influenza A
pathogenesis.
Summary of animal studies
Mouse models clearly demonstrate a strong genetic effect on
susceptibility to a range of influenza viruses. The Mx genes
are the best studied, but their relevance to susceptibility in
humans is unknown1 and although the MxA gene should be
considered a candidate gene for further studies, there are
many other candidates. Both the study by Boon et al. of
H5N1 and that by Boivin et al. of H3N2 found a continuum
of susceptibility in crossbred strains, suggesting that genetic
control of susceptibility to severe influenza in mice is
complex and not controlled by a single locus. Bottomly et al.
also identified a gradient of clinical responses following
H1N1 infection of crossbred mouse strains and identified 21
genes that may be involved in genetic control of RNA
expression at 4 days post-infection.
Human genetic studies
Four recently published human genetic studies of suscepti-
bility to influenza were identified.
Antonopoulou et al.11 investigated the frequency of three
SNPs in the tumour necrosis factor gene (TNF) in 109 A
(H1N1)pdm09 cases and 108 controls. The minor allele (A)
at position 238 of TNF (SNP rs361525) was more
common in cases (frequency = 0064) compared with
controls (frequency = 0019; P = 0016), and a diagnosis
of pneumonia was more common in cases with a least one
copy of the minor allele (7/13) compared with cases with no
copies of the minor allele (20/96). After correcting for
underlying disease in a logistic regression model, the
presence of at least one copy of the minor allele in cases
was associated with the development of pneumonia with a
P-value of 0045.
The same TNF polymorphism (rs361525) was also exam-
ined by Ferdinand et al.12, who compared the frequency of
eight polymorphisms of two candidate genes (three SNPs in
the tumour necrosis factor gene and five SNPs in themannose-
binding lectin gene) in 105 children and young adults with
fatal influenza infection compared with population controls.
Ferdinand et al. found no differences in genotype or allele
frequency between case and control groups. The minor allele
frequency (MAF) in the 108 controls examined by Antonop-
oulou et al. (0019) were lower than in the 1000 genomes
project (005) and the Ferdinand study (MAF cases 005),
which might explain the significant results. Ferdinand et al.
did report that fatal influenza cases with methicillin-resistant
Staphylococcus aureus (MRSA) co-infection had a higher
prevalence of a low-producingMBL2 genotype compared with
fatal cases without MRSA co-infection.
Keynan et al.13 examined the frequency of the chemokine
receptor 5 D32 (CCR5D32) allele (a 32 base pair deletion) in
20 critically ill patients with A(H1N1)pdm09. The CCR5D32
allele was not found in 10 non-white cases, but 5/9 white
cases were heterozygous for CCR5D32 (MAF = 028). The
CCR5D32 allele frequency in white cases was higher than has
been reported for healthy Caucasian controls, which is in the
range of 10–15%.
Chan et al.14 examined the frequency of immunoglobulin
heavy constant gamma 2 (IgHG2) allotypes and Fc gamma
receptor IIa (FcϒRIIa) genotype in 37 severe A(H1N1)
pdm09 cases. These two genes are associated with levels of
immunoglobulin subclass G2 (IgG2), which has been found
to be low in some patients with severe pH1N1 infection.15
Chan et al. reported that IgHG2 allotype was not associated
with IgG2 levels in severe A(H1N1)pdm09 cases, and
FcϒRIIa genotype frequencies were not significantly different
from that of the general Han Chinese population.
Horby et al.
38 ª 2013 Blackwell Publishing Ltd
Summary of human genetic studies
Although a number studies on genetic susceptibility to
influenza in humans have been published recently, all are
underpowered and unreplicated, so do not provide robust
statistical evidence of an association between the identified
genetic loci and susceptibility.
Mixed methods study
Everitt et al.16 tested the hypothesis that interferon-inducible
transmembrane protein 3 (IFITM3) is associated with
resistance to severe influenza A infection. Mice lacking a
functional Ifitm3 gene developed severe viral pneumonia
when challenged with a low-pathogenic, murine-adapted
H3N2 virus (A/X-31) and an A(H1N1)pdm09 virus (H1N1/
09Eng/195), and protection was re-established with reintro-
duction of IFTIM3. An Ifitm3 single nucleotide polymor-
phism (rs12252) was found at higher frequency in 53 people
hospitalised with A(H1N1)pdm09 compared with ethnically
matched controls (minor C allele frequency 0094 versus
0028; P-value 000006). Human lymphoblastoid cell lines
that are homozygous for the minor variant (CC) were more
susceptible to influenza A/H1N1 (A/WSN/1933) infection
and showed decreased levels of IFITM3 expression. When
compared to cells expressing wild-type IFITM3, cells
Table 1. Studies of host genetic susceptibility to influenza published between 26th June 2011 and 11th September 2012
Author (Year) Study/Investigation Main Reported Findings
Antonopoulou
A (2012)11
Candidate gene case-control association study of the
frequency of three SNPs in the tumour necrosis
factor gene (TNF) in 109 pH1N1 cases and 108 controls.
The minor allele (A) at position 238 of TNF (SNP rs361525) was
more common in cases (frequency = 0064) compared with
controls (frequency = 0019; P = 0016). A diagnosis of pneumonia
was more common in cases with a least one copy of the minor




Response to infection with a mouse adapted H3N2
(A/HK/1/68-MA20) in 29 recombinant congenic mouse
strains created from susceptible (A/J) and resistant
(C57BL/6J) mice. Genomic areas of interest identified by
co-localisation of clinical quantitative trait loci (cQTL)
and RNA expression quantitative trait loci (eQTL).
The most significant loci identified were Hc on chromosome 2,
and Pla2 g7 and Tnfrsf21 on chromosome 17.
Bottomly D
(2012)10
Animals with high and low response phenotypes following
infection with H1N1 (A/PR/8/34) were identified in 44
cross-bred mouse strains. Expression quantitative trait loci
mapping was performed on RNA transcripts that were
differentially expressed in high and low responders.
Twenty-one genes were identified that may be involved in genetic
control of RNA expression at 4 days post-infection.
Chan JF
(2011)14
Frequency of genetic factors that might affect IgGH2 level
by assessing their IgHG2 and Fc gamma receptor IIa
(FcϒRIIa) genotype in 38 severe pH1N1 cases.
Severe pH1N1 cases had lower levels of IgG2 than mild cases,
but IgHG2 allotype was not associated with IgG2 levels and
FcϒRIIa genotype frequencies did not differ from population
controls. The authors concluded that relative IgG2 suppression in




In-vitro and mouse studies of the role of interferon-inducible
transmembrane protein 3 (IFITM3) in resistance to severe
influenza infection. Frequency of Ifitm3 single nucleotide
polymorphism (rs12252) in 53 people hospitalised with
pH1N12009 compared with ethnically matched controls.
Mice lacking a functional Ifitm3 gene developed severe viral
pneumonia when challenged with normally low-pathogenic
viruses, and protection was re-established with reintroduction of
IFTIM3. Ifitm3 SNP rs12252 was found at higher frequency in
cases compared with ethnically matched controls.
Ferdinands
JM (2011)12
Frequency of 8 SNP’s in TNF and MBL genes in 105 children
and young adults with fatal influenza compared with
population controls.
No differences in genotype or allele frequency between case and
control groups. Fatal influenza cases with methicillin-resistant
Staphylococcus aureus (MRSA) co-infection had a higher
prevalence of a low-producing MBL2 genotype compared with
fatal cases without MRSA co-infection.
Juno J
(2012)17
Review of ‘immunogenetic’factors associated with severe
pH1N1 and avian influenza.
Although the influence of genetic polymorphisms on susceptibility
to severe pH1N1 and H5N1 have not been systematically
examined, various strands of evidence suggest host
immunogenetic variation could play an important role.
Keynan
Y (2010)13
A descriptive study of the frequency of the chemokine
receptor 5 D32 (CCR5D32) allele in 20 patients with
severe pandemic (H1N1) 2009.
The CCR5D32 was not found in 10 non-white cases, and was
present in 5/9 white cases. The proportion of white cases with
the CCR5D32 allele was higher than has been reported for
healthy Caucasian controls.
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expressing the variant of the IFITM3 protein associated with
the minor allele failed to restrict replication of A/H1N1 (A/
WSN/1933; A/California/7/2009), A/H3N2 (A/Uruguay/716/
2007) and B (B/Brisbane/60/2008). Although the human
genetics data alone are insufficiently robust to conclude,
there is an association between Ifitm3 polymorphisms and
susceptibiltiy to severe influenza, Everitt et al. presented
convincing functional evidence for an important role for
IFITM3 in susceptibility to severe influenza in mice and
some evidence that this may also be important in humans.
An effect of IFITM3 has now been observed for influenza A
subtypes H3N2, H1N1, H5N1 and influenza B.
Review article
One new review article was identified. Juno et al.17 reviewed
a range of immunobiological, gene expression and genetic
polymorphism data to explore immunological and genetic
factors that may be associated with severe pH1N1 and
H5N1disease.
Discussion
Work summarised here and in the earlier review demon-
strates that, in mice at least, the severity of influenza infection
is clearly associated with both the pathogen and host
genome. The observation that similar patterns of suscepti-
bility or resistance of specific mouse strains are observed for a
wide range of influenza viruses suggests that some of the host
genetic determinants of susceptibility to severe disease may
be common across influenza subtypes. The IFITM3 variant
explored by Everitt et al. shows an effect across influenza A
subtypes H3N2, H1N1 and influenza B. The papers by Boivin
et al. and Bottomly et al. support earlier work showing that
susceptibility in mice is polygenic, but the translation of
genetic data obtained in mice to humans is challenging.
Nevertheless, susceptibility to severe seasonal or pandemic
influenza in humans is also likely to be polygenic, as well as
being codetermined by pathogen characteristics, prior infec-
tion history, comorbidities and environmental factors. Many
candidate genes for susceptibility to severe influenza have
been proposed, but to date, evidence in humans has only
been presented for the Ifitm3 gene. This gene was selected for
investigation based on a priori data on the role of IFITM3 in
resistance to influenza A, and the majority of evidence for its
importance is based on in-vitro work. Given the large
number of genes that have been identified as playing a
potential role in susceptibility to severe influenza in humans,
hypothesis-free genome-wide association studies are attrac-
tive but are frustrated by the difficulty of recruiting sufficient
numbers of well-characterised severe influenza cases to
conduct adequately powered and replicable analyses.
The emergence and persistence of a new H1N1 variant (A
(H1N1)pdm09) offers a rare opportunity to study genetic
susceptibility to severe influenza in a context that, compared
with seasonal influenza strains that have circulated for
longer, is less confounded by infection history and pathogen
diversity. However, large sample sizes will still be required to
detect alleles with a small effect size, and case selection will
need to consider confounding by cross-protective immunity,
comorbidity and viral heterogeneity. Several groups have
compiled series of severe A(H1N1)pdm09 cases, but no
single group currently has sufficient cases to conduct an
adequately powered genetic study. To have a realistic
prospect of identifying susceptibility loci for A(H1N1)
pdm09, groups will need to form a consortium, as has been
successful for other diseases, to compile case cohorts both
retrospectively and prospectively.18
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